Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Gamgee raises $4M in seed funding led by Founders Fund to develop AI-powered personalized mRNA cancer vaccines for dogs.

PRIVATEAug 24, 2026•about 3 hours ago

Amount Raised

$4 Million

Round Type

Seed

AustraliaBiotechnologyHealth CareArtificial IntelligenceMachine Learning

Investors

Arash FerdowsiCeline HaliouaY CombinatorFounders Fund

Description

Gamgee, based in Australia, has secured $4 million in seed funding to scale its operations and accelerate the development of life-saving veterinary treatments. The funding will support clinical trials and the expansion of its end-to-end closed-loop platform. Gamgee aims to reduce vaccine design time to under 48 hours while lowering treatment costs. Founded by AI expert Paul Conyngham in 2026, Gamgee is focused on curing cancer in dogs.

Company Information

Company

Gamgee

Location

Australia

About

Gamgee is a startup based in Australia developing an AI-powered platform to create personalized mRNA cancer vaccines for dogs. Founded in 2026 by AI expert Paul Conyngham, the company aims to bring these innovative veterinary treatments to the global market. Gamgee utilizes a data-driven platform that integrates tumor sequencing, AI protein modeling, and automated vaccine design for targeted immunotherapy. The company has recently secured $4 million in seed funding to scale its operations and accelerate development.

Don't miss Gamgee's next move

Get an email the moment Gamgee raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Gamgee's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Gamgee raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.